Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v14-EN | Version v4-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2022-02-09 | 2021-11-10 |
| Drug Identification Number | 02209721 | 02209721 |
| Brand name | HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ | HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ |
| Common or Proper name | Heparin Sodium in 5% Dextrose Injection 25,000 USP Units / 250 mL | Heparin Sodium in 5% Dextrose Injection 25,000 USP Units / 250 mL |
| Company Name | B. BRAUN MEDICAL INC | B. BRAUN MEDICAL INC |
| Ingredients | DEXTROSE HEPARIN SODIUM | DEXTROSE HEPARIN SODIUM |
| Strength(s) | 5G 10000UNIT | 5G 10000UNIT |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 250 mL | 250 mL |
| ATC code | B01AB | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Shortage of an inactive ingredient or component. | Shortage of an inactive ingredient or component. |
| Anticipated start date | 2021-12-15 | 2021-12-15 |
| Actual start date | 2021-12-15 | |
| Estimated end date | 2022-03-31 | Unknown |
| Actual end date | 2022-02-08 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |